You are here

Home › Jim Shamp

Jim Shamp

Senior Editor
Phone number: 
919-541-9366
E-mail: 
jim_shamp@ncbiotech.org
LinkedIn

Jim Shamp writes and edits news and other web copy, brochures and other internal and external Biotechnology Center materials, and supports the Corporate Communications unit’s marketing and media relations activities.

Background

Shamp joined the Biotechnology Center in 2005, bringing to the organization nearly four decades of professional experience in writing, editing, marketing and advertising. This includes some 18 years of newspaper, broadcast, wire service and Web journalism in Illinois, Indiana, Michigan and North Carolina as well as a decade of public-relations activity at major global pharmaceutical companies' headquarters in Michigan and North Carolina. He has also started or been involved in establishing several entrepreneurial ventures.

He participates in a variety of professional, community-service and educational boards and committees.

Shamp holds a B.S. degree in communications from Manchester (Ind.) College.

Articles

BioMoto, NCRC Win Collaboration Awards

Two North Carolina life-science collaborations are among five award winners in last week’s second annual Przirembel Prize competition at the InnoVenture Conference in Greenville, South Carolina.

By:
Jim Shamp
Advanced Liquid Adds to Pool of Awards

Advanced Liquid Logic  is a company to watch.

That was reinforced this week when the fast-growing Research Triangle Park firm was named one of 25 North Carolina Companies to Watch from more than 200 nominees in the third annual competition sponsored by Durham-based entrepreneurial support organization CED. 

By:
Jim Shamp
2 N.C. Biotech Researchers Join National Academy

The North Carolina Biotechnology Center is joining three of the Triangle’s major research universities basking in the glow of scientific achievement bestowed upon two more local research scientists.

By:
Jim Shamp
NCBiotech Gives 3 Teachers Career Boosts

Three of the 44 teachers across North Carolina receiving prestigious Kenan Fellowships have also enjoyed career boosts from North Carolina Biotechnology Center programs.

Two of them participated in 2011 NCBiotech Summer Biotechnology Workshops for Educators, and the other received a grant in 2007 to help set up a biotech classroom.

By:
Jim Shamp
Like NCBiotech, UNC System Goes for the Gould
  Fred Gould. Photo courtesy of NCSU  

It seems the North Carolina Biotechnology Center has a lot of company in its admiration for North Carolina State University bug man Fred Gould, Ph.D.

By:
Jim Shamp
Four NC Vaccine Companies Win Awards

Four companies that contribute to North Carolina’s reputation as “Vaccine Central” were 2012 winners of the only dedicated awards honoring the accomplishments of the vaccine industry.

Arbovax, Medicago, Novartis Vaccines and Diagnostics and Quintiles brought home ViE Awards from the fifth World Vaccine Congress. The four were winners from among 14 different categories Wednesday at the Washington, D.C., gathering of more than 350 vaccine executives.

Arbovax, a Raleigh firm developing a Dengue fever vaccine, won for presenting the best poster session.

By:
Jim Shamp
United Unveils Non-Stop RDU-San Francisco

Venture forth, all ye seekers of venture funding. For RDU travelers, California’s deep pockets are now just a hop away. Forget the skip and the jump.

United Airlines today unveiled a long-sought non-stop service between Raleigh-Durham International Airport and San Francisco.

The travel breakthrough, announced by Gov. Bev Perdue during a celebration near the United ticket counter at RDU, leaves the Triangle airport at 7 a.m. and departs from SFO at 1 p.m. Pacific time.

By:
Jim Shamp
Corning Paying $730M for BD division

BD's factory in Durham included in $730 Corning purchase.

Photo courtesy of BD

The 310 employees of BD Biosciences’ Durham manufacturing site will become Corning employees by the end of the year.

By:
Jim Shamp
Katharos In Running For NC IDEA Grant

Raleigh kidney disease therapeutics company Katharos is among the 25 semi-finalists in the NC IDEA Spring 2012 grants program.

Each semi-finalist has until mid-April to submit a more detailed proposal outlining why it should be among the four to six finalists to get grants of up to $50,000 for business-plan research and development. This year, 184 North Carolina-based startups applied for the competition.

By:
Jim Shamp
Industrial Fellowship Deadline May 3

Attention academic postdocs and other Ph.D. scientists: You have until May 3 to finish an application that could change your life.

That’s the deadline to apply for the North Carolina Biotechnology Center’s Industrial Fellowship Program.

These fellowships give select Ph.D. scientists a unique chance to get industry experience. In turn, they give companies access to new talent and expertise.

By:
Jim Shamp

Blogs

RTP Rotary Revels in Research Rock Star DeSimone

Some folks are known to think outside the box.

Joe DeSimone turns that old saw inside out and around. He builds new boxes. Unique, important ones. Boxes that can deliver and improve cancer drugs and vaccines. And besides boxes, he builds tubes and electrodes that also redefine medicine.

By:
Jim Shamp